acipimox: Clinical Trials

6 trials of acipimox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 enrolling by invitation, 1 terminated. 6 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Enrolling by invitation 1, Terminated 1
Phase 32Completed 2
Phase 11Completed 1

Follow acipimox: new trials by email Literature Review of acipimox trials Research Report on acipimox

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes
acipimox, Placebo Oral Capsule - Type 2 Diabetes
Phase 2 / Phase 3CompletedMedical University of Vienna82013-10-012017-04-04
Effects of Acipimox on Mitochondrial Function in Obesity
Acipimox, Placebo - Abdominal Obesity, Insulin Resistance
Phase 2CompletedMassachusetts General Hospital392012-05-012016-03-01
Metabolic Modulation as Treatment in Acute Heart Failure
acipimox - Acute Heart Failure
Phase 2TerminatedUniversity of Aarhus322007-03-012007-10-25
The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
acipimox, Placebo - Metabolic Syndrome
Phase 2 / Phase 3CompletedBrigham and Women's Hospital402006-04-012023-02-21
Free Fatty Acids and Vascular Function in Subjects With Diabetes
acipimox, placebo - Type 2 Diabetes Mellitus
Phase 1 / Phase 2CompletedBrigham and Women's Hospital402005-09-012018-09-25
Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia
Acipimox, Placebo - Eating Disorder, Bulimia Nervosa
Phase 2Enrolling by invitationCharles University, Czech Republic242003-05-062025-02-19

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Insulin Resistance (2)  ·  Bulimia Nervosa (1)  ·  Feeding and Eating Disorders (1)  ·  Hypertriglyceridemia (1)  ·  Metabolic Syndrome (1)  ·  Obesity, Abdominal (1)

Sponsors

Brigham and Women's Hospital (2)  ·  Charles University, Czech Republic (1)  ·  Massachusetts General Hospital (1)  ·  Medical University of Vienna (1)  ·  University of Aarhus (1)

Countries

United States (3)  ·  Austria (1)  ·  Denmark (1)

Top investigators

Joshua A. Beckman, M.D. (1)  ·  Kvido Smitka, M.D., Ph.D. (1)  ·  Mads Halbirk, dr. (1)  ·  Mark Creager, M.D. (1)  ·  Michael Krebs, Prof.MD (1)  ·  Steven Grinspoon, MD (1)

Results publications

PMID 26691888, PMID 31571412, PMID 39888728